title: Pathogenesis of pediatric multiple sclerosis.
abstract: Onset of multiple sclerosis in childhood occurs in 3-5% of patients. There is limited, but growing knowledge about the underlying pathobiology of pediatric MS. It is crucial to better understand this area in order to address central questions in the field: 1) Can pediatric multiple sclerosis inform us about factors related to disease initiation and propagation? 2) What are the biomarkers of disease course in pediatric multiple sclerosis; 3) Does pediatric multiple sclerosis pathogenesis differ from adult-onset multiple sclerosis; 4) How can we optimize treatment in pediatric demyelinating diseases? 5) Can pediatric multiple sclerosis provide insights into the environmental risk factors for multiple sclerosis in general? Here we review the current knowledge of the pathogenesis of multiple sclerosis in children, and address the five questions raised above.
authors.affiliation: Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA 02114, USA.
authors.forename: David
authors.initials: D
authors.lastname: Vargas-Lowy
authors.forename: Tanuja
authors.initials: T
authors.lastname: Chitnis
mesh_terms: D017668:Age of Onset; D000818:Animals; D015984:Causality; D002648:Child; D018450:Disease Progression; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D012307:Risk Factors; D017678:Sex Distribution